Ask AI
ProCE Banner Activity

When Does Oncology Innovation Become Too Expensive?

Video

In this MedBuzz, Dr John Marshall examines the rising cost of cancer treatments and the difficult questions surrounding the value of innovation including the nearly $40,000 monthly price of daraxonrasib, and the broader challenge of balancing medical advances with access to care.

Released: September 29, 2026